| 9.00 - 9.30 |
Registration |
|
| 9.30 - 9.45 |
Introduction |
Professor Stephen Bloom |
| 9.45 - 10.15 |
Pharmacology of statins |
Dr Fergus McTaggart, AstraZeneca |
| 10.15 - 10.45 |
Anti-atherosclerotic
actions of statins |
Professor James Liao
Harvard Medical School
Boston, USA |
| 10.45 - 11.00 |
Discussion |
|
| 11.00 - 11.30 |
TEA/COFFEE BREAK |
|
| 11.30 - 12.00 |
The impact of
statins on CHD |
Dr Malcolm Law
St Bartholomew's & the Royal London
School of Medicine, London |
| 12.00 - 12.30 |
Clinical results of statins
in diabetes |
Dr John Betteridge
University College Hospital, London |
| 12.30 - 12.45 |
Discussion |
|
| 12.45 - 13.45 |
LUNCH |
|
|
|
|
| Chairman: |
Professor Gilbert Thompson |
|
| 13.45 - 14.15 |
Factors influencing
response to statins |
Professor Gilbert Thompson |
| 14.15 - 14.45 |
Who should we treat
in a resource-limited environment? |
Professor Larry Ramsey
University of Sheffield |
| 14.45 - 15.00 |
Discussion |
|
| 15.00 - 15.30 |
TEA/COFFEE |
|
| 15.30 - 16.00 |
Current US guidelines |
Professor Roger Illingworth
Oregon Health Sciences University
Portland, USA |
| 16.00 - 16.30 |
How low should we go
in lowering cholesterol? |
Professor Anton Stalenhoef
University Medical Centre Nijmegen,
The Netherlands |
| 16.30 - 16.45 |
Discussion |
|
| 16.45 - 17.00 |
Summary |
Professor Stephen Bloom
Professor Gilbert Thompson |
